Assessment of a large panel of candidate biomarkers of ageing in the Newcastle 85+ study

Mechanisms of Ageing and Development

Volumn 132, Issue 10, 2011, Pages 496-502

  Martin Ruiz, Carmen ^a   Jagger, Carol ^a   Kingston, Andrew ^a   Collerton, Joanna ^a   Catt, Michael ^a   Davies, Karen ^a   Dunn, Mick ^a   Hilkens, Catharien ^a   Keavney, Bernard ^a   Pearce, Simon H S ^a   den Elzen, Wendy P J ^b   Talbot, Duncan ^c   Wiley, Laura ^a   Bond, John ^a   Mathers, John C ^a   Eccles, Martin P ^a   Robinson, Louise ^a   James, Oliver ^a   Kirkwood, Thomas B L ^a   von Zglinicki, Thomas ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNILEVER RESEARCH   (United Kingdom)

Author keywords

Ageing; Biomarkers; Cohort study; Health status

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; BILIRUBIN; CALCIUM; CHOLESTEROL; CREATININE; CYANOCOBALAMIN; FERRITIN; FOLIC ACID; GLUCOSE; HEMOGLOBIN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROCORTISONE; LIOTHYRONINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHATE; POTASSIUM; PYRIDOXINE; SODIUM; THYROTROPIN; THYROXINE; TRIACYLGLYCEROL; URATE; UREA; VITAMIN D;

AGED; AGING; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; COGNITIVE DEFECT; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DEATH; DISABILITY; DISEASE MARKER; ERYTHROCYTE; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH STATUS; HEMATOCRIT; HUMAN; INFLAMMATION; LEUKOCYTE; LIOTHYRONINE BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR VOLUME; MONOCYTE; MORBIDITY; MORTALITY; NUTRITION; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; SEX DIFFERENCE; SODIUM BLOOD LEVEL; TELOMERE; THROMBOCYTE; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; UNITED KINGDOM; UREA BLOOD LEVEL; URIC ACID BLOOD LEVEL;

AGED; AGED, 80 AND OVER; AGING; BIOLOGICAL MARKERS; COHORT STUDIES; CROSS-SECTIONAL STUDIES; ENGLAND; FEMALE; HEALTH STATUS INDICATORS; HUMANS; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS;

EID: 80053384309     PISSN: 00476374     EISSN: 18726216     Source Type: Journal    
DOI: 10.1016/j.mad.2011.08.001     Document Type: Article

References (36)

1. Anderson J.L., May H.T., Horne B.D., Bair T.L., Hall N.L., Carlquist J.F., Lappe D.L., Muhlestein J.B. Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am. J. Cardiol. 2010, 106:963-968.
2. Baker G.T., Sprott R.L. Biomarkers of aging. Exp. Gerontol. 1988, 23:223-239.
3. Bohannon R.W. Hand-grip dynamometry predicts future outcomes in aging adults. J. Geriatr. Phys. Ther. 2008, 31:3-10.
4. Cawthon R.M., Smith K.R., O'Brien E., Sivatchenko A., Kerber R.A. Association between telomere length in blood and mortality in people aged 60 years or older. Lancet 2003, 361:393-395.
5. Collerton J., Barrass K., Bond J., Eccles M., Jagger C., James O., Martin-Ruiz C., Robinson A.L., Von Zglinicki T., Kirkwood T. The Newcastle 85+ study: biological, clinical and psychosocial factors associated with health ageing: study protocol. BMC Geriatr. 2007, 7:14.
6. Collerton J., Davies K., Jagger C., Kingston A., Bond J., Eccles M.P., Robinson A.L., Martin-Ruiz C., Von Zglinicki T., James O.F.W., Kirkwood T. Health and disease in 85 years olds: baseline findings from the Newcastle 85+ cohort study. BMJ 2009, 399(Part b4904):1-11.
7. Cooper R., Kuh D., Hardy R. Objectively measured physical capability levels and mortality: systematic review and meta-analysis. BMJ 2010, 341:c4467.
8. Davies K., Collerton J.C., Jagger C., Bond J., Barker S.A.H., Edwards J., Hughes J., Hunt J.M., Robinson A.L. Engaging the oldest old in research: lessons from the Newcastle 85+ study. BMC Geriatr. 2010, 10.
9. den Elzen W.P., Willems J.M., Westendorp R.G., de Craen A.J., Assendelft W.J., Gussekloo J. Effect of anemia and comorbidity on functional status and mortality in old age: results from the Leiden 85-plus Study. CMAJ 2009, 3-4.
10. Derhovanessian E., Maier A.B., Beck R., Jahn G., Hahnel K., Slagboom P.E., de Craen A.J., Westendorp R.G., Pawelec G. Hallmark features of immunosenescence are absent in familial longevity. J. Immunol. 2010, 185:4618-4624.
11. Donda A., Lemarchand-Beraud T. Aging alters the activity of 5'-deiodinase in the adenohypophysis, thyroid gland, and liver of the male rat. Endocrinology 1989, 124:1305-1309.
12. Euser S.M., van Bemmel T., Schram M.T., Gussekloo J., Hofman A., Westendorp R.G., Breteler M.M. The effect of age on the association between blood pressure and cognitive function later in life. J. Am. Geriatr. Soc. 2009, 57:1232-1237.
13. Fatourechi V. Upper limit of normal serum thyroid-stimulating hormone: a moving and now an aging target?. J. Clin. Endocrinol. Metab. 2007, 92:4560-4562.
14. Forestier E., Vinzio S., Sapin R., Schlienger J.L., Goichot B. Increased reverse triiodothyronine is associated with shorter survival in independently-living elderly: the Alsanut study. Eur. J. Endocrinol. 2009, 160:207-214.
15. Franceschi C., Bonafe M., Valensin S., Olivieri F., De Luca M., Ottaviani E., De Benedictis G. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann. N. Y. Acad. Sci. 2000, 908:244-254.
16. Guralnik J.M., Eisenstaedt R.S., Ferrucci L., Klein H.G., Woodman R.C. Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood 2004, 104:2263-2268.
17. Houben J.M., Giltay E.J., Rius-Ottenheim N., Hageman G.J., Kromhout D. Telomere length and mortality in elderly men: the Zutphen elderly study. J. Gerontol. A. Biol. Sci. Med. Sci. 2010.
18. Kirkwood T.B. Alex Comfort and the measure of aging. Exp. Gerontol. 1998, 33:135-140.
19. Kistorp C., Raymond I., Pedersen F., Gustafsson F., Faber J., Hildebrandt P. N-terminal pro-brain natriuretic peptide. C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults. JAMA 2005, 293:1609-1616.
20. Llewellyn D.J., Lang I.A., Langa K.M., Muniz-Terrera G., Phillips C.L., Cherubini A., Ferrucci L., Melzer D. Vitamin D and risk of cognitive decline in elderly persons. Arch. Intern. Med. 2010, 170:1135-1141.
21. Mariotti S., Barbesino G., Caturegli P., Bartalena L., Sansoni P., Fagnoni F., Monti D., Fagiolo U., Franceschi C., Pinchera A. Complex alteration of thyroid function in healthy centenarians. J. Clin. Endocrinol. Metab. 1993, 77:1130-1134.
22. Martin-Ruiz C., Dickinson H.O., Keys B., Rowan E., Kenny R.A., Von Zglinicki T. Telomere length predicts poststroke mortality, dementia, and cognitive decline. Ann. Neurol. 2006, 60:174-180.
23. Martin-Ruiz C.M., Gussekloo J., van Heemst D., von Zglinicki T., Westendorp R.G. Telomere length in white blood cells is not associated with morbidity or mortality in the oldest old: a population-based study. Aging Cell 2005, 4:287-290.
24. Ochs N., Auer R., Bauer D.C., Nanchen D., Gussekloo J., Cornuz J., Rodondi N. Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality. Ann. Intern. Med. 2008, 148:832-845.
25. Rolland Y., Lauwers-Cances V., Cesari M., Vellas B., Pahor M., Grandjean H. Physical performance measures as predictors of mortality in a cohort of community-dwelling older French women. Eur. J. Epidemiol. 2006, 21:113-122.
26. Sabia S., Shipley M., Elbaz A., Marmot M., Kivimaki M., Kauffmann F., Singh-Manoux A. Why does lung function predict mortality? Results from the Whitehall II Cohort Study. Am. J. Epidemiol. 2010, 172:1415-1423.
27. Schaap L.A., Pluijm S.M., Deeg D.J., Harris T.B., Kritchevsky S.B., Newman A.B., Colbert L.H., Pahor M., Rubin S.M., Tylavsky F.A., Visser M. Higher inflammatory marker levels in older persons: associations with 5-year change in muscle mass and muscle strength. J. Gerontol. A. Biol. Sci. Med. Sci. 2009, 64:1183-1189.
28. Seplaki C.L., Goldman N., Weinstein M., Lin Y. How Are Biomarkers Related to Physical and Mental Well-Being?. J. Gerontol. Biol. Sci. 2004, 59A:201-217.
29. Sprott R.L. Biomarkers of aging and disease: introduction and definitions. Exp. Gerontol. 2010, 45:2-4.
30. Strindhall J., Nilsson B.O., Lofgren S., Ernerudh J., Pawelec G., Johansson B., Wikby A. No immune risk profile among individuals who reach 100 years of age: findings from the Swedish NONA immune longitudinal study. Exp. Gerontol. 2007, 42:753-761.
31. Tiainen K., Hurme M., Hervonen A., Luukkaala T., Jylha M. Inflammatory markers and physical performance among nonagenarians. J. Gerontol. A. Biol. Sci. Med. Sci. 2010, 65:658-663.
32. Vaes B., de Ruijter W., Degryse J., Westendorp R.G., Gussekloo J. Clinical relevance of a raised plasma N-terminal pro-brain natriuretic peptide level in a population-based cohort of nonagenarians. J. Am. Geriatr. Soc. 2009, 57:823-829.
33. van Bemmel T., Vinkers D.J., Macfarlane P.W., Gussekloo J., Westendorp R.G. Markers of autonomic tone on a standard ECG are predictive of mortality in old age. Int. J. Cardiol. 2006, 107:36-41.
34. van den Beld A.W., Visser T.J., Feelders R.A., Grobbee D.E., Lamberts S.W. Thyroid hormone concentrations, disease, physical function, and mortality in elderly men. J. Clin. Endocrinol. Metab. 2005, 90:6403-6409.
35. van den Berg E., Biessels G.J., de Craen A.J., Gussekloo J., Westendorp R.G. The metabolic syndrome is associated with decelerated cognitive decline in the oldest old. Neurology 2007, 69:979-985.
36. Wikby A., Månsson I., Johansson B., Strindhall J., Nilsson S. The immune risk profile is associated with age and gender: findings from three Swedish population studies of individuals 20-100 years of age. Biogerontology 2008, 9:299-308.